Metabolic changes of different high-resolution computed tomography phenotypes of COPD after budesonide–formoterol treatment
Cheng Wang,1 Jun-Xiong Li,1 Dang Tang,2 Jian-Qing Zhang,1 Li-Zhou Fang,1 Wei-Ping Fu,1 Ling Liu,1 Lu-Ming Dai1 1Second Department of Respiratory Medicine, 2First Department of Neurosurgery, The First Affiliated Hospital of Kunming Medical University, Kunming, People’s Republic of China B...
Main Authors: | Wang C, Li JX, Tang D, Zhang JQ, Fang LZ, Fu WP, Liu L, Dai LM |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-12-01
|
Series: | International Journal of COPD |
Subjects: | |
Online Access: | https://www.dovepress.com/metabolic-changes-of-different-high-resolution-computed-tomography-phe-peer-reviewed-article-COPD |
Similar Items
-
Functional respiratory imaging assessment of budesonide/glycopyrrolate/formoterol fumarate and glycopyrrolate/formoterol fumarate metered dose inhalers in patients with COPD: the value of inhaled corticosteroids
by: Maarten van den Berge, et al.
Published: (2021-07-01) -
Cost-effectiveness analysis of budesonide/formoterol (Symbicort(R)) as needed for mild asthma in Malaysia
by: Gopal, VR, et al.
Published: (2021) -
Triple Therapy with Budesonide/Glycopyrrolate/Formoterol Fumarate Improves Inspiratory Capacity in Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap
by: Ishiura Y, et al.
Published: (2020-02-01) -
Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts
by: Shigeo Muro, et al.
Published: (2021-06-01) -
Risks of budesonide/formoterol for the treatment of stable COPD: a meta-analysis
by: Tang B, et al.
Published: (2019-04-01)